Leukemia-associated phenotypes: Their characteristics and incidence in acute leukemia

Neoplasma

Volumn 43, Issue 6, 1996, Pages 367-372

  Babusikova O ^a   Glasova M ^a   Konikova E ^a   Kusenda, J ^a  

^a INSTITUTE OF CHEMISTRY   (Slovakia)

Author keywords

acute leukemia; leukemia associated phenotypes; minimal residual disease; quantitative flow cytometry

Indexed keywords

ACUTE LEUKEMIA; ARTICLE; BLAST CELL; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; MAJOR CLINICAL STUDY; MINIMAL RESIDUAL DISEASE;

EID: 0029953399     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. BABUŠÍKOVÁ, O., MESÁROSOVÁ, A., KONÍKOVÁ, E., KUSENDA, J., GLASOVÁ, M., KLOBUŠICKÁ, M.: Leukemia-associated marker combinations in acute leukemia suitable for detection of minimal residual disease. Neoplasma, 40, 1993, 275-281.
2. BABUŠÍKOVÁ, O., GLASOVÁ, M., KUSENDA. J., KONÍKOVÁ, E., MESÁROŠOVÁ, A.: Flow cytometric determination of leukemia-associated marker combinations for the study of minimal residual disease. Neoplasma, 41, 1994, 305-313.
3. BIONDI, A., RAMBALDI, A., ALCALAY, M., PANDOLFI, P.P., LOCOCO, E, DIVERIO, D., ROSSI, V., MENCARELLI, A., LONGO, L., ZANGRILLI, D., MASERA, G., BARBUI, P., MANDELLI, F., GRIGNANI, F., PELICCI, P.G.: Rar-alfa gene rearrangements as genetic marker for diagnosis and monitoring in acute promyelocytic leukemia. Blood, 77, 1991, 1418-1422.
4. CAMPANA, D., COUSTAN-SMITH, E., JANOSSY, G.: The immunologic detection of minimal residual disease in acute leukemia. Blood, 76, 1990, 163-171.
5. CAMPANA, D., PLI, CH.: Detection of minimal residual disease in acute leukemia: Methodologic advances and clinical significance. Blood, 85, 1995, 1416-1434.
6. COUSTAN-SMITH, E., BEHM, F.G., HURWITZ, C.A., RIVER, G.,K., CAMPANA, D.: N-Cam (CD56) expression by CD34+ malignant mycloblasts has implications for minimal residual disease detection in acute myeloid leukemia. Leukemia, 7, 1993, 853-858.
7. DE THE, H., CHOMIENNE, C., LANOTTE, M., DEGOS, L., DEJEAN, A.: The t(15;17) of acute promyelocytic leukemia fuses the retinoic acid receptor alfa gene to a novel transcribed locus. Nature, 347, 1990, 558-561.
8. DRACH, J., GATTRINGER, C., HUBER, H.: Combined flow cytometric assessment of cell surface antigens and nuclear TdT for the detection of minimal residual disease in acute leukaemia. Br. J. Haematol., 77, 1991, 37-42.
9. DRACH, J., DRACH, D., GLASSL, H., GATTRINGER, C., HUBER, H.: Flow cytometric determination of atypical antigen expression in acute leukemia for the study of minimal residual disease. Cytometry, 13, 1992, 893-901.
10. DRACH, D., DRACH, J., GLASSL, H., GATTRINGER, C., HUBER, H.: Flow cytometric detection of cytoplasmic antigens in acute leukemias: Implications for lineage assignment. Leuk. Res., 17, 1993, 455-461.
11. FARAHAT, N., LENS, D., ZOMAS, A., MORILLA, R., MATUTES, E., CATOVSKY, D.: Quantitative flow cytometry can distinguish between normal and leukaemic B-cell precursors. Br. J. Haematol., 91, 1995, 640-646.
12. FEY, M.F., KULOZIK, A.E., HANSEN-HAGGE, T.E., TOBLER, A.: The polymerase chain reaction: A new tool for detection of minimal residual disease in haematological malignancies. Eur. J. Cancer, 27, 1991, 89-94.
13. FOON, K.A., TODD, R.F.: Immunologic classification of leukemia and lymphoma. Blood, 68, 1986, 1-41.
14. GLASOVÁ, M., KONICOVÁ, E., KUSENDA, J., BABUŠIKOVÁ, O.: Evaluation of different fixation-permeabilization methods for simultaneous detection of surface, cytoplasmic markers and DNA analysis by flow cytometry in some human hematopoietic cell lines. Neoplasma, 42, 1995, 337-346.
15. KATZ, F., BALL, L., GIBBSON, B., CHESSELS, J.: The use of DNA probes to monitor minimal residual disease in childhood acute lymphoblastic leukaemia. Br. J. Haematol., 73, 1989, 173-180.
16. KNAPP, W., STROBL, H., MAJDIC, O.: Flow cytometric analysis of cell-surface and intracellular antigens in leukemia diagnosis. Cytometry, 18, 1994, 187-198.
17. MACEDO, A., ORFAO, A., VIDRIALES, M.B., LÓPEZ-BERGES, M. C., VALVERDE, B., GONZÁLEZ, M., CABALLERO, M.D., RAMOS, F., MARTÍNEZ, M., FERNÁNDEZ-CALVO, J., MARTÍNEZ, A., SAN MIGUEL, J.F.: Characterization of aberrant phenotypes in acute myeloblastic leukemia. Ann. Hematol., 70, 1995, 189-194.
18. ORFAO, A., CIUDAD, J., LÓPEZ-BERGES, M.C., LÓPEZ, A., VIDRIALES, B., CABALLERO, M.D., VALVERDE, B., GONZÁLEZ, M., SAN MIGUEL, J.F.: Acute lymphoblastic leukemia (ALL): Detection of minimal residual disease (MRD) at flow cytometry. Leuk. Lymphoma, 13, 1994, 87-90.
19. PHILIP, P., SARTIAUX, C., and the GEIL: Standardized multicentric quantimetry of differentiation antigens expression. The GEIL' s approach in acute lymphoblastic leukemia. Leuk. Lymphoma, 13, 1994, 45-48.
20. RAGHAVACHAR, A., THIEL, E., BARTRAM, C.R.: Analysis of phenotype and genotype in acute lymphoblastic leukemia at presentation and relapse. Blood, 70, 1987, 1083-1097.
21. TERSTAPPEN, L.W.M.M., SAFFORD, M., KONEMANN, S., LOKEN, N.R., ZURLUTTER, K., BÜCHNER, T., HIDDEMANN, W., WÖRMANN, B.: Flow cytometric characterization of acute myeloid leukemia. II. Phenotypic heterogeneity at diagnosis. Leukemia, 5, 1991, 757-767.
22. VAN DONGEN, J.J.M., BREIT, T.M., ADRIAANSEN, H.J., BEISHUIZEN, A., HOOIJKAAS, H.: Detection of minimal residual disease in acute leukemia by immunological marker analysis and polymerase chain reaction. Leukemia, 6, 1992, 47-59.